Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03398915Active Not Recruiting

The European Robotic Spinal Instrumentation (EUROSPIN) Study

Role: lead

NCT02998060Not ApplicableWithdrawn

Clinical Evidence of Robot Guided vs. Navigated vs. Free Hand Lumbar Spinal Fusion

Role: lead

NCT03303300Completed

The Five-repetition Sit-to-stand Test for Lower Back Pain or Radiculopathy

Role: lead

All 3 trials loaded